Abstract
Digoxin-drug interactions are relatively common causes of digitalis toxicity. Recently, the clinical importance of the renal tubular secretion of digoxin has been proven by documenting drug interactions at this level. The authors describe a model using cultured renal tubular cell monolayers that can be used to predict drug interactions with the cardiac glycoside. This model accurately documents known clinical digoxin interactions such as those with verapamil and propafenone. The common feature of these interactions is that they involve P-glycoprotein substrates (e.g., digoxin, vincristine, vinblastine) or inhibitors (e.g., quinidine, cyclosporine). In the case of the newly described interaction of digoxin with itraconazole, the model preceded the emergence of clinical cases.
References
Mar 15, 1992·Annals of Internal Medicine·J Rex
Nov 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A Kauffman, F A Bagnasco
Nov 1, 1987·Clinical Pharmacokinetics·G Koren
Apr 15, 1985·The American Journal of Cardiology·G Koren, R Parker
Jul 1, 1974·Circulation·E Steiness
Oct 1, 1995·The Journal of Clinical Investigation·A H SchinkelP Borst
Jan 1, 1993·Canadian Journal of Physiology and Pharmacology·S ItoM Silverman
Jan 1, 1993·Life Sciences·S ItoG Koren
Feb 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K L McClean, G J Sheehan
Jan 1, 1993·Life Sciences·S ItoG Koren
Mar 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M K SachsP J Green
Nov 1, 1996·Pharmacology & Toxicology·J PartanenP J Neuvonen
Apr 1, 1997·The Annals of Pharmacotherapy·C P Alderman, P D Allcroft
Citations
Jul 16, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Gershon HolcbergZvi Ben-Zvi
Oct 30, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Elnaz GozalpourJan B Koenderink
Feb 28, 2007·Clinical and Experimental Pharmacology & Physiology·Stanislav MicudaJirina Martinkova
Jan 31, 2009·Epilepsia·Facundo Garcia BournissenYaron Finkelstein
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Er-jia WangWilliam W Johnson
Nov 25, 2005·Pediatric Research·Natasha PintoGideon Koren
Jul 11, 2001·Pharmacotherapy·C J MathenyG M Pollack
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Dec 12, 2001·Clinical Pharmacokinetics·F Pea, M Furlanut
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tsuyoshi MikkaichiTakaaki Abe
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·Meng LiJoanne Wang
Oct 27, 2004·Journal of Veterinary Pharmacology and Therapeutics·M KurohaM Shimoda
Nov 4, 2004·Chemico-biological Interactions·Jinghai J XuPeter J O'Brien
Dec 21, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Christopher J EndresJashvant D Unadkat
Feb 13, 2003·British Journal of Clinical Pharmacology·Christer TannergrenHans Lennernäs
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Tsuyoshi MikkaichiTakaaki Abe
Aug 27, 2003·Journal of Pharmacological Sciences·Keiji YamamotoToshifumi Watanabe
Mar 24, 2016·Antimicrobial Agents and Chemotherapy·Vincent J C LempersJan B Koenderink
Sep 4, 2007·The Oncologist·Serena MarchettiJan H M Schellens
Aug 21, 2010·Journal of Pharmacological Sciences·Jeff Hughes, Andrew Crowe
Apr 7, 2017·Drugs·Marie LundKim Peder Dalhoff
Feb 24, 2001·The Annals of Pharmacotherapy·P A KublerJ R McKay
Sep 19, 2002·Journal of the American Podiatric Medical Association·Arush K Angirasa, Ada Z Koch